Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 1 |
2007 | 1 |
2011 | 1 |
2013 | 2 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study.
Lancet Oncol. 2020 Apr;21(4):519-530. doi: 10.1016/S1470-2045(19)30863-0. Epub 2020 Mar 12.
Lancet Oncol. 2020.
PMID: 32171426
Clinical Trial.
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group.
Davies C, et al.
Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1.
Lancet. 2013.
PMID: 23219286
Free PMC article.
Clinical Trial.
Item in Clipboard
Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial).
Ramalingam S, Crawford J, Chang A, Manegold C, Perez-Soler R, Douillard JY, Thatcher N, Barlesi F, Owonikoko T, Wang Y, Pultar P, Zhu J, Malik R, Giaccone G; FORTIS-M Study Investigators.
Ramalingam S, et al.
Ann Oncol. 2013 Nov;24(11):2875-80. doi: 10.1093/annonc/mdt371. Epub 2013 Sep 19.
Ann Oncol. 2013.
PMID: 24050956
Free article.
Clinical Trial.
Item in Clipboard
Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia.
Plakhins G, Irmejs A, Gardovskis A, Subatniece S, Rozite S, Bitina M, Keire G, Purkalne G, Teibe U, Trofimovics G, Miklasevics E, Gardovskis J.
Plakhins G, et al. Among authors: bitina m.
BMC Med Genet. 2011 Oct 27;12:147. doi: 10.1186/1471-2350-12-147.
BMC Med Genet. 2011.
PMID: 22032251
Free PMC article.
Item in Clipboard
Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
Irmejs A, Borosenko V, Melbarde-Gorkusa I, Gardovskis A, Bitina M, Kurzawski G, Suchy J, Gorski B, Gardovskis J.
Irmejs A, et al. Among authors: bitina m.
Anticancer Res. 2007 Jan-Feb;27(1B):653-8.
Anticancer Res. 2007.
PMID: 17348456
Free article.
Item in Clipboard
Pilot study on low penetrance breast and colorectal cancer predisposition markers in latvia.
Irmejs A, Miklasevics E, Boroschenko V, Gardovskis A, Vanags A, Melbarde-Gorkusa I, Bitina M, Suchy J, Gardovskis J.
Irmejs A, et al. Among authors: bitina m.
Hered Cancer Clin Pract. 2006 Jan 15;4(1):48-51. doi: 10.1186/1897-4287-4-1-48.
Hered Cancer Clin Pract. 2006.
PMID: 20223004
Free PMC article.
Item in Clipboard
Clinical, molecular and geographical features of hereditary breast/ovarian cancer in latvia.
Gardovskis A, Irmejs A, Miklasevics E, Borosenko V, Bitina M, Melbarde-Gorkusa I, Vanags A, Kurzawski G, Suchy J, Górski B, Gardovskis J.
Gardovskis A, et al. Among authors: bitina m.
Hered Cancer Clin Pract. 2005 Apr 15;3(2):71-6. doi: 10.1186/1897-4287-3-2-71.
Hered Cancer Clin Pract. 2005.
PMID: 20223033
Free PMC article.
Item in Clipboard
Cite
Cite